TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/6/2025 | $12.00 → $15.00 | Buy | TD Cowen |
| 9/1/2023 | $11.00 → $12.00 | Outperform | TD Cowen |
| 3/4/2022 | $32.00 → $23.00 | Outperform | Cowen |
| 11/22/2021 | $27.00 | Outperform | Northland Capital |
| 11/22/2021 | $24.00 | Market Perform | BMO Capital Markets |
| 11/22/2021 | $30.00 | Outperform | Cowen |
| 11/22/2021 | $33.00 | Buy | Jefferies |
| 11/22/2021 | $35.00 | Buy | Rosenblatt |
4 - Arteris, Inc. (0001667011) (Issuer)
4 - Arteris, Inc. (0001667011) (Issuer)
4 - Arteris, Inc. (0001667011) (Issuer)
CAMPBELL, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Blaize has adopted FlexNoC 5 interconnect IP to enhance the performance and scalability of the Blaize AI Platform, a programmable, energy-efficient foundation for hybrid AI deployment models spanning edge and cloud infrastructure. The network-on-chip IP from Arteris enables efficient AI data movement, high-performance computing, and reductions in power consumption and time-to-market. Highly configurable and performance-optimized, Arteris FlexNoC empowers Blaize to advance its platform architecture to meet
CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history," said K. Charles Janac, President and CEO of Ar
CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Altera has licensed Arteris' broad product portfolio for the development of next-generation FPGA and SoC FPGA solutions. Arteris IP and software products will be used to streamline design workflows, optimize data movement, and enable intelligent computing across data center, communications, vision, industrial automation, robotics, aerospace, and defense applications. Altera is the largest independent FPGA solutions provider, delivering end-to-end programmable solutions that scale across the data center t
SCHEDULE 13G/A - Arteris, Inc. (0001667011) (Subject)
10-Q - Arteris, Inc. (0001667011) (Filer)
8-K - Arteris, Inc. (0001667011) (Filer)
TD Cowen reiterated coverage of Arteris with a rating of Buy and set a new price target of $15.00 from $12.00 previously
TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously
Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously
CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history," said K. Charles Janac, President and CEO of Ar
CAMPBELL, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. Management will host a conference call on Tuesday, November 4, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be availabl
CAMPBELL, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the second quarter ended June 30, 2025 and provided estimated third quarter and updated full year 2025 guidance. "In the second quarter of 2025, we achieved record Annual Contract Value plus royalties of $69.1 million and exited the quarter with $99.3 million in Remaining Performance Obligations, with the latter representing a year-over-year increase of 28%," said K. Charles Janac, President and CEO of Arteris. "Looking ahead, we remain confident in Arteris' long-term growth opp
CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where
SC 13G/A - Arteris, Inc. (0001667011) (Subject)
SC 13G - Arteris, Inc. (0001667011) (Subject)
SC 13G/A - Arteris, Inc. (0001667011) (Subject)